retatrutide trial status Breaking: New data just released. TRIUMPH-1 study results on the triple agonist. Eli Lilly's clinical trial on Retatrutide (triple agonist compound). 80 weeks. Phase 3 data. The results: At 12mg retatrutide clinical trials status 2025

US$ 27.02

★★★★★ 4.1 (30 reviews)

US$ 23.57

★★★★★ 4.8 (8 reviews)

US$ 21.40

★★★★★ 5.0 (10 reviews)

US$ 23.52

★★★★★ 4.6 (13 reviews)

US$ 21.68

★★★★★ 4.6 (29 reviews)

US$ 21.60

★★★★★ 4.4 (9 reviews)

US$ 24.81

★★★★★ 4.9 (17 reviews)

US$ 21.76

★★★★★ 4.1 (12 reviews)

US$ 25.90

★★★★★ 4.6 (16 reviews)

US$ 28.91

★★★★★ 4.7 (24 reviews)

US$ 26.45

★★★★★ 4.2 (12 reviews)

US$ 21.77

★★★★★ 4.1 (17 reviews)

US$ 20.20

★★★★★ 4.4 (23 reviews)

US$ 25.02

★★★★★ 4.3 (20 reviews)

US$ 22.63

★★★★★ 4.0 (15 reviews)

US$ 25.86

★★★★★ 4.4 (14 reviews)

US$ 21.99

★★★★★ 4.4 (21 reviews)

US$ 22.39

★★★★★ 4.5 (30 reviews)

US$ 20.92

★★★★★ 4.7 (5 reviews)

US$ 29.58

★★★★★ 5.0 (13 reviews)